BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34535063)

  • 21. Health care policy and cancer survivorship.
    Virgo KS; Bromberek JL; Glaser A; Horgan D; Maher J; Brawley OW
    Cancer; 2013 Jun; 119 Suppl 11():2187-99. PubMed ID: 23695931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving structural development in oncology: transformation of theoretical health care standards and knowledge into a practical approach -- 2nd European Roundtable Meeting (ERTM), May 8, 2015, Berlin, Germany.
    Ortmann O; Torode J; Helbig U
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):807-11. PubMed ID: 26481367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Essential medicines list in national cancer control plans: a secondary analysis from a global study.
    Razis E; Kassapian M; Andriakopoulou C; Martei YM; Zurn SJ; Hammad N; Romero Y; Dafni U; Ilbawi AM; Trapani D
    Lancet Oncol; 2022 Mar; 23(3):e144-154. PubMed ID: 35240089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National action for European public health research.
    McCarthy M; Zeegers Paget D; Barnhoorn F
    Eur J Public Health; 2013 Nov; 23 Suppl 2():43-6. PubMed ID: 24189796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007.
    Gouveia J; Coleman MP; Haward R; Zanetti R; Hakama M; Borras JM; Primic-Zakelj M; de Koning HJ; Travado L
    Eur J Cancer; 2008 Jul; 44(10):1457-62. PubMed ID: 18325756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathology and Laboratory Medicine in cancer care: A global analysis of national cancer control plans.
    Parra-Herran C; Romero Y; Milner D
    Int J Cancer; 2021 Apr; 148(8):1938-1947. PubMed ID: 33152147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Policy statement on multidisciplinary cancer care.
    ; Borras JM; Albreht T; Audisio R; Briers E; Casali P; Esperou H; Grube B; Hamoir M; Henning G; Kelly J; Knox S; Nabal M; Pierotti M; Lombardo C; van Harten W; Poston G; Prades J; Sant M; Travado L; Valentini V; van de Velde C; van den Bogaert S; van den Bulcke M; van Hoof E; van den Neucker I; Wilson R
    Eur J Cancer; 2014 Feb; 50(3):475-80. PubMed ID: 24321260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind.
    Espina C; Soerjomataram I; Forman D; Martín-Moreno JM
    J Cancer Policy; 2018 Dec; 18():40-51. PubMed ID: 30510896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public Health Innovation and Research in Europe: introduction to the supplement.
    McCarthy M; Zeegers Paget D
    Eur J Public Health; 2013 Nov; 23 Suppl 2():2-5. PubMed ID: 24189788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two decades of change in European general practice service profiles: conditions associated with the developments in 28 countries between 1993 and 2012.
    Schäfer WL; Boerma WG; Spreeuwenberg P; Schellevis FG; Groenewegen PP
    Scand J Prim Health Care; 2016; 34(1):97-110. PubMed ID: 26862927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance.
    Burgard P; Rupp K; Lindner M; Haege G; Rigter T; Weinreich SS; Loeber JG; Taruscio D; Vittozzi L; Cornel MC; Hoffmann GF
    J Inherit Metab Dis; 2012 Jul; 35(4):613-25. PubMed ID: 22544437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey.
    Deandrea S; Molina-Barceló A; Uluturk A; Moreno J; Neamtiu L; Peiró-Pérez R; Saz-Parkinson Z; Lopez-Alcalde J; Lerda D; Salas D
    Prev Med; 2016 Oct; 91():250-263. PubMed ID: 27527575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Health Interview Surveys and Health Examination Surveys in the European Union.
    Aromaa A; Koponen P; Tafforeau J; Vermeire C;
    Eur J Public Health; 2003 Sep; 13(3 Suppl):67-72. PubMed ID: 14533752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
    Burns R; Leal J; Sullivan R; Luengo-Fernandez R
    Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Policy on palliative care in the WHO European region: an overview of progress since the Council of Europe's (2003) recommendation 24.
    Woitha K; Carrasco JM; Clark D; Lynch T; Garralda E; Martin-Moreno JM; Centeno C
    Eur J Public Health; 2016 Apr; 26(2):230-5. PubMed ID: 26545804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European survey of hepatitis B vaccination policies for healthcare workers: An updated overview.
    De Schryver A; Lambaerts T; Lammertyn N; François G; Bulterys S; Godderis L
    Vaccine; 2020 Mar; 38(11):2466-2472. PubMed ID: 32057571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An international comparison of stakeholder motivation to implement liver cancer control.
    Bridges JF; Joy SM; Blauvelt BM; Yan W; Marsteller JA
    Health Policy Plan; 2015 Jun; 30(5):645-55. PubMed ID: 24974105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe.
    Rossi E; Vita A; Baccetti S; Di Stefano M; Voller F; Zanobini A
    Support Care Cancer; 2015 Jun; 23(6):1795-806. PubMed ID: 25471177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.